Evidence map›Paper›PMID 23975535›Full record

ArticleMetabolic brain disease2013

Protective effects of N-acetylcysteine on 3, 4-methylenedioxymethamphetamine-induced neurotoxicity in male Sprague-Dawley rats.

Sara Soleimani Asl, Kazem Mousavizadeh, Kazem Mousavizedeh, Bagher Pourheydar, Mansoureh Soleimani, Elnaz Rahbar, Mehdi Mehdizadeh

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Metabolic brain disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Effect ofEvidence-based complementary and alternative medicine : eCAM · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Protective Effects ofBasic and clinical neuroscience
    Article
  14. Article
4 · The record

Corrections and comments

  • Erratum issued
    Mousavizedeh, Kazem [Corrected to Mousavizadeh, Kazem]
5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Sara Soleimani AslResearch Center for Behavioral Disorders and Substance Abuse, Hamadan University of Medical Sciences, Hamadan, Iran.
Kazem Mousavizadeh
Kazem Mousavizedeh
Bagher Pourheydar
Mansoureh Soleimani
Elnaz Rahbar
Mehdi Mehdizadeh
Tehran University of Medical Sciences · IRHamedan University of Medical Sciences · IRSemnan University of Medical Sciences · IRUrmia University of Medical Sciences

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exposure to 3, 4-methylenedioxymethamphetamine (MDMA) leads to spatial memory impairment and hippocampal cell death. In the present study we have examined the protective effects of N-acetyl-L-cysteine (NAC) on MDMA-induced neurotoxicity. A total of 56 male Sprague Dawley rats (200-250 g) received twice daily intraperitoneal (IP) injections of 5, 10 or 20 mg/kg MDMA plus NAC (100 mg/kg). Rectal temperatures were recorded before and after daily treatment. We used a Morris water maze (MWM) to assess spatial learning and memory. At the end of the study rats' brains were removed, cells were counted and the level of Bcl-2, Bax and caspase-3 expression in the hippocampi were measured. NAC pretreatment significantly reduced MDMA-induced hyperthermia. In the MWM, NAC significantly attenuated the MDMA-induced increase in distance traveled; however the observed increase in escape latency was not significant. The decrease in time spent in the target quadrant in MDMA animals was significantly attenuated (p < 0.001, all groups). NAC protected against MDMA-induced cell death and the up -regulation of Bax and Caspase-3, in addition to the down-regulation of Bcl-2. This data suggested a possible benefit of NAC in the treatment of neurotoxicity among those who use MDMA.

Indexed as

AcetylcysteineAnimalsbcl-2-Associated X ProteinCaspase 3Cell DeathDown-RegulationHippocampusMaleMaze LearningNeurotoxicity SyndromesN-Methyl-3,4-methylenedioxyamphetamineProto-Oncogene Proteins c-bcl-2RatsRats, Sprague-DawleyAcetylcysteineBax protein, ratbcl-2-Associated X ProteinCaspase 3N-Methyl-3,4-methylenedioxyamphetamineProto-Oncogene Proteins c-bcl-2

Identifiers

PMID23975535
OpenAlexW2060772857

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.